2k56 Citations

NMR structure of the bank vole prion protein at 20 degrees C contains a structured loop of residues 165-171.

J Mol Biol 383 306-12 (2008)
Cited: 53 times
EuropePMC logo PMID: 18773909

Abstract

The recent introduction of bank vole (Clethrionomys glareolus) as an additional laboratory animal for research on prion diseases revealed an important difference when compared to the mouse and the Syrian hamster, since bank voles show a high susceptibility to infection by brain homogenates from a wide range of diseased species such as sheep, goats, and humans. In this context, we determined the NMR structure of the C-terminal globular domain of the recombinant bank vole prion protein (bvPrP) [bvPrP(121-231)] at 20 degrees C. bvPrP(121-231) has the same overall architecture as other mammalian PrPs, with three alpha-helices and an antiparallel beta-sheet, but it differs from PrP of the mouse and most other mammalian species in that the loop connecting the second beta-strand and helix alpha2 is precisely defined at 20 degrees C. This is similar to the previously described structures of elk PrP and the designed mouse PrP (mPrP) variant mPrP[S170N,N174T](121-231), whereas Syrian hamster PrP displays a structure that is in-between these limiting cases. Studies with the newly designed variant mPrP[S170N](121-231), which contains the same loop sequence as bvPrP, now also showed that the single-amino-acid substitution S170N in mPrP is sufficient for obtaining a well-defined loop, thus providing the rationale for this local structural feature in bvPrP.

Articles - 2k56 mentioned but not cited (7)

  1. NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features. Ilc G, Giachin G, Jaremko M, Jaremko Ł, Benetti F, Plavec J, Zhukov I, Legname G. PLoS One 5 e11715 (2010)
  2. Discordant and chameleon sequences: their distribution and implications for amyloidogenicity. Gendoo DM, Harrison PM. Protein Sci 20 567-579 (2011)
  3. Asparagine and glutamine ladders promote cross-species prion conversion. Kurt TD, Aguilar-Calvo P, Jiang L, Rodriguez JA, Alderson N, Eisenberg DS, Sigurdson CJ. J Biol Chem 292 19076-19086 (2017)
  4. Recombinant PrPSc shares structural features with brain-derived PrPSc: Insights from limited proteolysis. Sevillano AM, Fernández-Borges N, Younas N, Wang F, R Elezgarai S, Bravo S, Vázquez-Fernández E, Rosa I, Eraña H, Gil D, Veiga S, Vidal E, Erickson-Beltran ML, Guitián E, Silva CJ, Nonno R, Ma J, Castilla J, R Requena J. PLoS Pathog 14 e1006797 (2018)
  5. The landscape of the prion protein's structural response to mutation revealed by principal component analysis of multiple NMR ensembles. Gendoo DM, Harrison PM. PLoS Comput Biol 8 e1002646 (2012)
  6. Deciphering Copper Coordination in the Mammalian Prion Protein Amyloidogenic Domain. Salzano G, Brennich M, Mancini G, Tran TH, Legname G, D'Angelo P, Giachin G. Biophys J 118 676-687 (2020)
  7. Insight into the conserved structural dynamics of the C-terminus of mammal PrPC identifies structural core and possible structural role of pharmacological chaperones. Soto P, Gloeb GM, Tsuchida KA, Charles AA, Greenwood NM, Hendrickson H. Prion 17 55-66 (2023)


Reviews citing this publication (5)

  1. Prion protein misfolding and disease. Moore RA, Taubner LM, Priola SA. Curr Opin Struct Biol 19 14-22 (2009)
  2. Cross-species transmission of CWD prions. Kurt TD, Sigurdson CJ. Prion 10 83-91 (2016)
  3. Probing early misfolding events in prion protein mutants by NMR spectroscopy. Giachin G, Biljan I, Ilc G, Plavec J, Legname G. Molecules 18 9451-9476 (2013)
  4. Structural factors underlying the species barrier and susceptibility to infection in prion disease. Sweeting B, Khan MQ, Chakrabartty A, Pai EF. Biochem Cell Biol 88 195-202 (2010)
  5. Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C). Gill AC, Agarwal S, Pinheiro TJ, Graham JF. Prion 4 235-242 (2010)

Articles citing this publication (41)